Open Access. Powered by Scholars. Published by Universities.®
Social and Behavioral Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 3 of 3
Full-Text Articles in Social and Behavioral Sciences
An Expansion Of A Model Of Depression In Multiple Sclerosis : Emotion Regulation And Coping As Moderators Of The Relationship Between Functional Disability And Adjustment To Disease, Elizabeth W. Raffanello
An Expansion Of A Model Of Depression In Multiple Sclerosis : Emotion Regulation And Coping As Moderators Of The Relationship Between Functional Disability And Adjustment To Disease, Elizabeth W. Raffanello
Legacy Theses & Dissertations (2009 - 2024)
Multiple sclerosis (MS) is an immune-mediate disease affecting the central nervous system (CNS), producing a range of physical and emotional symptoms. Psychological disorders, particularly depression and anxiety, are common in MS, but only partially accounted for by MS symptoms. The associations between common MS sequelae (e.g., fatigue, pain, disability) and mental health indicators are weak and inconsistent, suggesting the presence of moderators. This research study examined two possible moderators of the association between MS sequelae and adjustment to disease: emotion regulation and coping. Emotion regulation refers to the processes used to modulate emotional experiences. It is closely related to coping, …
Classification Of Major Depression In College Students : A Grade Of Membership Analysis, Ishani Ravindra Deo
Classification Of Major Depression In College Students : A Grade Of Membership Analysis, Ishani Ravindra Deo
Legacy Theses & Dissertations (2009 - 2024)
The disease burden of major depressive disorder is at its greatest among college-aged individuals, and frequently leads to long-term negative outcomes. However, within and across racial/ethnic groups, there are significant differences in how the disorder manifests and the resulting impact. Conceptualizing depression in a way that accurately reflects this variation is therefore a crucial task. In the current study, grade of membership (GoM) analyses were used to derive “fuzzy set” depression profiles in a college sample for each of the five major racial/ethnic groups in the United States. The primary sample consisted of 22,778 European, African, Hispanic/Latino, Asian/Pacific Islander, and …
Ayahuasca's Antidepressant Effects Covary With Behavioral Activation As Well As Mindfulness, Maha N. Mian
Ayahuasca's Antidepressant Effects Covary With Behavioral Activation As Well As Mindfulness, Maha N. Mian
Legacy Theses & Dissertations (2009 - 2024)
Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on observed changes in mindfulness. The present study investigated if both mindfulness and behavioral activation might also contribute to these anti-depressant effects. We surveyed individuals (N = 152) about their changes in depressive symptoms, Behavioral Activation, and mindfulness after an Ayahuasca experience. Mindfulness was strongly associated with reduced depression severity (r = -.670, p < .001), while behavioral activation was moderately linked (r = -.474, p < .001). Changes in depressive symptoms (Center for Epidemiological Sciences Depression Short Form [CES-D-10]) covaried with subscales from the Five Facet Mindfulness Questionnaire [FFMQ] and Experiences Questionnaire [EQ], confirming previous findings (beta = -.57, [95% CI (- 5.70) - (- 3.25)], p < .001). In addition, a modification of the Behavioral Activation for Depression Scale-Short Form [BADS-SF] accounted for significant unique variance in the improvements in depression (beta = -.16, [95% CI (-6.32) - (-0.08)], p < .05). These results suggest that changes in behavioral activation likely serve as an important mechanism underlying Ayahuasca’s antidepressant effects. Future clinical trials could benefit from tracking behavioral activation. In addition, a concerted focus on increasing valued, positive activities might enhance Ayahuasca’s anti-depressant effects.